Back to company

JJ PHARMA CONSULT ApS: Financial statements 2013

CVR: 33257635

JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -8,909 and a net result of DKK 94,586 compared with DKK 22,154 the year before. Equity amounted to DKK 183,451. The solvency ratio was 32.3%.

Gross Profit
-8,909 kr.
Profit/Loss
94,586 kr.
Equity
183,451 kr.
Total Assets
567,749 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013--9 t.95 t.183 t.-
2012--6 t.22 t.89 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like JJ PHARMA CONSULT ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2013

JJ PHARMA CONSULT ApS: The 2012 annual report is outMay 6, 2013

JJ PHARMA CONSULT ApS has published its annual report for 2012. Gross profit came to DKK -6,438, and the net result was DKK 22,154.

About JJ PHARMA CONSULT ApS

JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity amounted to DKK 16,917,153.